
FDA’s top drug regulator resigns after federal officials probe ‘serious concerns’
The head of the Food and Drug Administration’s drug center abruptly resigned Sunday amid concerns about his personal conduct. A federal spokesperson said Dr. George Tidmarsh left the agency after federal lawyers began looking into “serious concerns about his personal conduct,” according to an official statement. Tidmarsh had been serving as the FDA’s top regulator since July. His resignation came the same day that a drugmaker filed a lawsuit against him alleging “false and defamatory statements” about its products. The drugmaker, Aurinia Pharmaceuticals, is chaired by one of Tidmarsh’s former business associates.


















































































